HUP9904141A1 - Kriptoficinszármazékok és ezeket a vegyületeket tartalmazó gyógyszerkészítmányek - Google Patents

Kriptoficinszármazékok és ezeket a vegyületeket tartalmazó gyógyszerkészítmányek

Info

Publication number
HUP9904141A1
HUP9904141A1 HU9904141A HUP9904141A HUP9904141A1 HU P9904141 A1 HUP9904141 A1 HU P9904141A1 HU 9904141 A HU9904141 A HU 9904141A HU P9904141 A HUP9904141 A HU P9904141A HU P9904141 A1 HUP9904141 A1 HU P9904141A1
Authority
HU
Hungary
Prior art keywords
alkyl
mono
optionally substituted
lower alkyl
alkylamino
Prior art date
Application number
HU9904141A
Other languages
English (en)
Inventor
Rima S. Al-Awar
William Joseph Ehlhardt
Subbaraju V. Gottumukkala
Michael John Martinelli
Eric D. Moher
Richard E. Moore
John E. Munroe
Bryan H. Norman
Vinod F. Patel
James Edward Ray
Chuan Shih
John Eldon Toth
Venkatraghavan Vasudevan
Original Assignee
Eli Lilly And Co.,
University Of Hawaii
Wayne State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Co.,, University Of Hawaii, Wayne State University filed Critical Eli Lilly And Co.,
Priority claimed from PCT/US1997/015240 external-priority patent/WO1998008505A1/en
Publication of HUP9904141A1 publication Critical patent/HUP9904141A1/hu
Publication of HUP9904141A3 publication Critical patent/HUP9904141A3/hu
Publication of HU227195B1 publication Critical patent/HU227195B1/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D273/00Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/12Esters of phosphoric acids with hydroxyaryl compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A találmány tárgyát az (I) általánős képletű új kriptőficinvegyületekképezik, melyek annak köszönhetően, hőgy gátőlják a sejtmikrőtűbűláris rendszerének dinamikűs működését, megakadályőzzák asejtek mitőtikűs szapőrődását, és ezért neőplazma elleneshatóanyagként alkalmazhatók. A nevezett vegyületek antifűngicidtűlajdőnságőkkal is rendelkeznek. ŕ
HU9904141A 1996-08-30 1997-08-29 Kriptoficinszármazékok és ezeket a vegyületeket tartalmazó gyógyszerkészítmányek HU227195B1 (hu)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2581696P 1996-08-30 1996-08-30
US3953097P 1997-03-03 1997-03-03
US4002997P 1997-03-04 1997-03-04
US3905697P 1997-03-10 1997-03-10
PCT/US1997/015240 WO1998008505A1 (en) 1996-08-30 1997-08-29 Pharmaceutical compounds

Publications (3)

Publication Number Publication Date
HUP9904141A1 true HUP9904141A1 (hu) 2000-03-28
HUP9904141A3 HUP9904141A3 (en) 2001-08-28
HU227195B1 HU227195B1 (hu) 2010-10-28

Family

ID=27487440

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9904141A HU227195B1 (hu) 1996-08-30 1997-08-29 Kriptoficinszármazékok és ezeket a vegyületeket tartalmazó gyógyszerkészítmányek

Country Status (4)

Country Link
KR (1) KR100505779B1 (hu)
HU (1) HU227195B1 (hu)
NZ (1) NZ334127A (hu)
PL (1) PL331919A1 (hu)

Also Published As

Publication number Publication date
HUP9904141A3 (en) 2001-08-28
HU227195B1 (hu) 2010-10-28
NZ334127A (en) 2000-07-28
KR100505779B1 (ko) 2005-08-04
KR20000035919A (ko) 2000-06-26
PL331919A1 (en) 1999-08-16

Similar Documents

Publication Publication Date Title
DE60128936D1 (en) Aza- und polyaza-naphthalenylcarbonsäureamide als hiv-integrase-hemmer
DE60124577D1 (en) Aza- und polyaza-naphthalenylcarbonsäureamide als hiv-integrase-hemmer
YU41500A (sh) Novi makrolidi
IL110643A0 (en) Amidine derivatives, their preparation and pharmaceutical compositions containing them
MY140488A (en) Substituted oxazolidinones and their use in the field of blood coagulation
MXPA03010790A (es) Heterociclos biciclicos que contienen nitrogeno para uso como antibacterianos.
MXPA04003932A (es) Inhibidores de la hidroxipirimidinona carboxamida n-sustituida de la integrasa del virus de inmunodeficiencia humana.
MY133027A (en) C-4"-substituted macrolide derivatives
HUP0400241A2 (hu) Hatóanyagként triaza-spiro[5.5]undekán-származékokat tartalmazó gyógyszerkészítmények
AP2001002142A0 (en) 13-membered azalides and their use as antibiotic agents.
UA42699C2 (uk) Бензоксазинонові сполуки, спосіб інгібування зворотної транскриптази, попередження або лікування, комбінації та фармацевтичні композиції
AP2001002131A0 (en) Novel macrolide antibiotics.
IL123655A (en) Substituted tetracyclic tetrahydrofuran derivatives and pharmaceutical compositions containing them
HUP0202656A2 (hu) 1-Amino-triazolo[4,3-a]kinazolin-5-on- és/vagy -5-tion-származékok foszfodiészteráz-IV gátlására, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
MY133995A (en) 6-phenylpyrrolopyrimidinedione derivatives
YU102503A (sh) Kondenzovani pirimidinski dhfr inhibitori kao antibakterijska sredstva
BR0002577A (pt) Suspensões orais de trovafloxacina
IL165259A0 (en) Compounds useful in the treatment of anthraxa and inhibiting lethal factor
HUP9904141A1 (hu) Kriptoficinszármazékok és ezeket a vegyületeket tartalmazó gyógyszerkészítmányek
NZ507452A (en) Hygromycin a derivatives
NZ502861A (en) Method of treating livestock bacterial respiratory or enteric infections using 9a-azalides
SG146685A1 (en) Dihydroporphine derivatives, processes for their preparation, and pharmaceutical compositions containing them
MXPA04005179A (es) Un metodo para tratar infecciones bacterianas usando gemifloxacina o una sal de la misma y una antibiotico de (-lactama.
MXPA02011966A (es) Derivados de higromicina a para el el tratamiento de infecciones bacterianas y por protozoarios.
AP2001002154A0 (en) Hygromycin a derivatives (changed by the ISA to read hygromycin a derivatives as antibacterial agents.

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees